Research ArticleArticle
Mycophenolate Mofetil in Nonrenal Manifestations of Systemic Lupus Erythematosus: An Observational Cohort Study
Konstantinos Tselios, Dafna D. Gladman, Jiandong Su and Murray B. Urowitz
The Journal of Rheumatology January 2016, jrheum.150779; DOI: https://doi.org/10.3899/jrheum.150779
Konstantinos Tselios
From the Centre for Prognosis Studies in Rheumatic Diseases, University of Toronto Lupus Clinic, University Health Network, Toronto, Ontario, Canada. Konstantinos Tselios is financially supported by the Geoff Carr Fellowship from Lupus Ontario. K. Tselios, MD, PhD, Centre for Prognosis Studies in Rheumatic Diseases, University of Toronto Lupus Clinic, University Health Network; D.D. Gladman, MD, FCRPC, Centre for Prognosis Studies in Rheumatic Diseases, University of Toronto Lupus Clinic, University Health Network; J. Su, MB, BSc, Centre for Prognosis Studies in Rheumatic Diseases, University of Toronto Lupus Clinic, University Health Network; M.B. Urowitz, MD, FRCPC, Centre for Prognosis Studies in Rheumatic Diseases, University of Toronto Lupus Clinic, University Health Network. Address correspondence to Dr. M.B. Urowitz, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, 399 Bathurst St., 1E-410B, Toronto, Ontario M5T 2S8, Canada. E-mail: m.urowitz@utoronto.ca. Accepted for publication November 24, 2015.
Dafna D. Gladman
From the Centre for Prognosis Studies in Rheumatic Diseases, University of Toronto Lupus Clinic, University Health Network, Toronto, Ontario, Canada. Konstantinos Tselios is financially supported by the Geoff Carr Fellowship from Lupus Ontario. K. Tselios, MD, PhD, Centre for Prognosis Studies in Rheumatic Diseases, University of Toronto Lupus Clinic, University Health Network; D.D. Gladman, MD, FCRPC, Centre for Prognosis Studies in Rheumatic Diseases, University of Toronto Lupus Clinic, University Health Network; J. Su, MB, BSc, Centre for Prognosis Studies in Rheumatic Diseases, University of Toronto Lupus Clinic, University Health Network; M.B. Urowitz, MD, FRCPC, Centre for Prognosis Studies in Rheumatic Diseases, University of Toronto Lupus Clinic, University Health Network. Address correspondence to Dr. M.B. Urowitz, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, 399 Bathurst St., 1E-410B, Toronto, Ontario M5T 2S8, Canada. E-mail: m.urowitz@utoronto.ca. Accepted for publication November 24, 2015.
Jiandong Su
From the Centre for Prognosis Studies in Rheumatic Diseases, University of Toronto Lupus Clinic, University Health Network, Toronto, Ontario, Canada. Konstantinos Tselios is financially supported by the Geoff Carr Fellowship from Lupus Ontario. K. Tselios, MD, PhD, Centre for Prognosis Studies in Rheumatic Diseases, University of Toronto Lupus Clinic, University Health Network; D.D. Gladman, MD, FCRPC, Centre for Prognosis Studies in Rheumatic Diseases, University of Toronto Lupus Clinic, University Health Network; J. Su, MB, BSc, Centre for Prognosis Studies in Rheumatic Diseases, University of Toronto Lupus Clinic, University Health Network; M.B. Urowitz, MD, FRCPC, Centre for Prognosis Studies in Rheumatic Diseases, University of Toronto Lupus Clinic, University Health Network. Address correspondence to Dr. M.B. Urowitz, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, 399 Bathurst St., 1E-410B, Toronto, Ontario M5T 2S8, Canada. E-mail: m.urowitz@utoronto.ca. Accepted for publication November 24, 2015.
Murray B. Urowitz
From the Centre for Prognosis Studies in Rheumatic Diseases, University of Toronto Lupus Clinic, University Health Network, Toronto, Ontario, Canada. Konstantinos Tselios is financially supported by the Geoff Carr Fellowship from Lupus Ontario. K. Tselios, MD, PhD, Centre for Prognosis Studies in Rheumatic Diseases, University of Toronto Lupus Clinic, University Health Network; D.D. Gladman, MD, FCRPC, Centre for Prognosis Studies in Rheumatic Diseases, University of Toronto Lupus Clinic, University Health Network; J. Su, MB, BSc, Centre for Prognosis Studies in Rheumatic Diseases, University of Toronto Lupus Clinic, University Health Network; M.B. Urowitz, MD, FRCPC, Centre for Prognosis Studies in Rheumatic Diseases, University of Toronto Lupus Clinic, University Health Network. Address correspondence to Dr. M.B. Urowitz, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, 399 Bathurst St., 1E-410B, Toronto, Ontario M5T 2S8, Canada. E-mail: m.urowitz@utoronto.ca. Accepted for publication November 24, 2015.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Mycophenolate Mofetil in Nonrenal Manifestations of Systemic Lupus Erythematosus: An Observational Cohort Study
Konstantinos Tselios, Dafna D. Gladman, Jiandong Su, Murray B. Urowitz
The Journal of Rheumatology Jan 2016, jrheum.150779; DOI: 10.3899/jrheum.150779